paclitaxel

Type: Keyphrase
Name: paclitaxel
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Roche receives European Commission approval for ovarian cancer therapy

F. Hoffmann-La Roche Ltd has received approval from the European Commission, or EU, for the use of Avastin in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin chemotherapy as a treatment for women with recurrent ovarian cancer ... [Published Individual.com - 18 hours ago]
First reported Aug 20 2014 - Updated 18 hours ago - 4 reports

Bristol-Myers, Celgene team up on cancer combination treatment

Wed 3:49 pm by ProactiveInvestors The plan is to launch a Phase I study pairing Bristol-Myers' nivolumab, a cancer treatment designed to bring about the death of tumor cells by blocking a pathway called PD-1; and Celgene's Abraxane, an injectable form ... [Published Proactive Investors USA - Aug 21 2014]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

Pemetrexed plus cisplatin active in advanced, recurrent cervical carcinoma

The combination of pemetrexed and cisplatin appeared safe and effective in women with advanced, persistent or recurrent carcinoma of the cervix, according to results of a phase 2 trial.“This combination should be further developed in the treatment of ... [Published Orthopedics Today - 22 hours ago]
First reported Aug 20 2014 - Updated Aug 20 2014 - 3 reports

FDA Approves Genentech's Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer

By a News Reporter-Staff News Editor at Biotech Week -- Genentech , a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved Avastin® (bevacizumab) in combination with paclitaxel and ... [Published 4 Traders - Aug 20 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

PACLITAXEL Injection, Solution [Fresenius Kabi USA, LLC]

First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Carcinoma of Unknown Primary Site Treated with Carboplatin + Paclitaxel + Bevacizumab + Erlotinib and Its Maintenance Chemotherapy

ReferencesHuebner G, Link H, Kohne CH, et al: Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. Br J Cancer 2009;100:44-49.Hainsworth ... [Published Sexual Development - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Combination therapy for the treatment of cancer

Described are methods and compositions for treating cancer that include a dopamine receptor (DR) antagonist such as thioridazine and a chemotherapeutic agent. Optionally, the chemotherapeutic agent is a DNA synthesis inhibitor such as cytarabine or a ... [Published Free Patents Online - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

FDA Approves Avastin for Advanced Cervical Cancer

The US Food and Drug Administration has approved bevacizumab (Avastin) for the treatment of patients with recurrent or metastatic cervical cancer. The drug is to be used in combination with paclitaxel and either cisplatin or topotecan.“Avastin is the ... [Published Cancernetwork.com - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 4 reports

Roche's Avastin Approved by FDA for Advanced Cervical Cancer

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into ... [Published Yahoo! Finance - Aug 18 2014]
First reported Aug 15 2014 - Updated Aug 16 2014 - 4 reports

Cervical Cancer Drug Approved by FDA

Avastin, the new drug developed for the treatment of several types of cancer  has finally been approved for the treatment of cervical cancer in combination with chemotherapy by the Food and Drug Administration. Avastin (containing bevacizumab, monoclonal ... [Published The Utah People's Post - Aug 16 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 15 reports

Avastin Gains New Indication for Metastatic Cervical Cancer

Share this article:The FDA has approved Avastinin for persistent, recurrent, or metastatic cervical cancer.Genentech has announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with paclitaxel and cisplatin ... [Published Chemotherapy Advisor - Aug 15 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

PACLITAXEL Injection, Solution [Fresenius Kabi USA, LLC]

Quotes

...is an important treatment goal in advanced disease," said Sandra Horning, M D , Roche's Chief Medical Officer and Head, Global Product Development. "Avastin is the first biologic medicine approved by the EU for women with this difficult to treat disease."
...to help them live longer than with chemotherapy alone," said Sandra Horning , M D , chief medical officer and head of Global Product Development. "Cervical cancer is most commonly diagnosed in women between the ages of 35 and 44, and until today, chemotherapy was the only approved treatment option for women whose cancer recurred, persisted or spread."
NEXT ARTICLE More From BioPortfolio on "Bristol-Myers Squibb, Celgene team upup to test combo cancer therapy"
...we expect will fund our clinical programs into the first half of 2016," said Robert Forrester , President and Chief Executive Officer of Verastem . "By targeting cancer stem cells, we want to change the way that cancer is treated. Through diligent execution by our research and development team, we continue to advance our portfolio of cancer stem cell targeting agents through clinical development."

More Content

All (316) | News (282) | Reports (0) | Blogs (26) | Audio/Video (0) | Fact Sheets (4) | Press Releases (2)
sort by: Date | Relevance
BMS And Celgene Collaborate For Combination Can... [Published Bioresearch Online - 10 hours ago]
Roche receives European Commission approval for... [Published Individual.com - 18 hours ago]
Pemetrexed plus cisplatin active in advanced, r... [Published Orthopedics Today - 22 hours ago]
Cardiovascular Toxicity Associated With Adjuvan... [Published General Medicine eJournal - 23 hours ago]
BMS and Celgene to research cancer immunotherap... [Published PMLive - Aug 21 2014]
Bristol-Myers, Celgene team up on cancer combin... [Published Proactive Investors USA - Aug 21 2014]
B-MS hooks up with Celgene to test cancer combo [Published Pharma Times - Aug 21 2014]
FDA Approves Genentech's Avastin Plus Chemother... [Published 4 Traders - Aug 20 2014]
BristolMyers Squibb Celgene team up to test com... [Published BioPortfolio - Aug 20 2014]
Bristol-Myers Squibb, Celgene team up to test c... [Published MedCity News - Aug 20 2014]
Bristol-Myers, Celgene plan to match an immuno-... [Published FierceBiotech - Aug 20 2014]
Bristol-Myers Squibb & Celgene Collaborate On I... [Published PharmaceuticalProcessing - Aug 20 2014]
FDA approves Avastin plus chemotherapy for trea... [Published European Pharmaceutical Manufacturer - Aug 20 2014]
Bristol-Myers and Celgene team up in cancer com... [Published Seeking Alpha - Aug 20 2014]
PACLITAXEL Injection, Solution [Fresenius Kabi ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Genentech: Avastin Plus Chemotherapy Secures FD... [Published Individual.com - Aug 20 2014]
Carcinoma of Unknown Primary Site Treated with ... [Published Sexual Development - Aug 19 2014]
Combination therapy for the treatment of cancer [Published Free Patents Online - Aug 19 2014]
Drug for Treatment of Platinum Resistant Recurr... [Published Biotech Daily - Aug 19 2014]
VERASTEM : Updates on Second Quarter Results [Published 4 Traders - Aug 19 2014]
FDA Approves Avastin for Advanced Cervical Cancer [Published Cancernetwork.com - Aug 19 2014]
Roche's Avastin Approved by FDA for Advanced Ce... [Published Yahoo! Finance - Aug 18 2014]
PHARMAC tender for generic medicines contribute... [Published Pharma Letter - Aug 18 2014]
Roche’s Avastin plus chemotherapy receives FDA ... [Published Pharmaceutical Technology - Aug 18 2014]
Data Published by Researchers from The Scripps ... [Published ADVFN India - Aug 18 2014]
Data Published by Researchers from The Scripps ... [Published ADVFN UK - Aug 18 2014]
Roches Avastin plus chemotherapy gets FDA appro... [Published BioPortfolio - Aug 18 2014]
Tender for generic medicines contributes $38 mi... [Published Scoop - Aug 18 2014]
Roche’s Avastin plus chemotherapy gets FDA appr... [Published PBR - News - Aug 18 2014]
Turkish company guilty of smuggling fake Avasti... [Published Examiner.com - Aug 17 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
PACLITAXEL Injection, Solution [Fresenius Kabi ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Updated Date: Aug 15, 2014 EST ...
Roche’s Avastin plus chemotherapy gets FDA appr... [Published PBR - News - Aug 18 2014]
Roche has received approval from the US Food and Drug Administration (FDA) for Avastin (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan to treat women with persistent, recurrent or metastatic carcinoma of the cer ...
PACLITAXEL Injection, Solution [Fresenius Kabi ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 15 2014]
Updated Date: Aug 15, 2014 EST ...
FDA Approves Genentech’s Avastin Plus Chemother... [Published EON Consumer - Aug 14 2014]
SOUTH SAN FRANCISCO, Calif.--(EON: Enhanced Online News)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Avastin® (bevacizumab) in combination with paclitaxel ...
FDA Approves Genentech’s Avastin Plus Chemother... [Published Business Wire Health News - Aug 14 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Avastin® (bevacizumab) in combination with paclitaxel and cisplatin ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Oasmia’s Lead Human Product Paclical® Successfu... [Published GlobeNewswire: Acquisitions News - Jun 16 2014]
Oasmia Receives FDA Conditional Approval For It... [Published GlobeNewswire: Acquisitions News - Feb 28 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.